Search Results
Dec 16, 2025, 08:00 ET MellingMedical Joins Forces with Converge Medical Technology to Bring Innovative Spine Care Solutions to the Federal Healthcare System
MellingMedical MellingMedical, an SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), holds a Medical Equipment and Surgical Federal Supply Schedule (Med/Surg), as well as a Pharmaceutical Schedule and ECAT capabilities, providing innovative and cost-effective healthcare solutions to all 172 VA Medical Centers
More news about: MellingMedical
Dec 16, 2025, 07:53 ET Club Med công bố hợp tác cùng công ty quản lý Alderan mở rộng thị trường Canada với dự án Club Med Tremblant
Club Med, thương hiệu toàn cầu tiên phong trong lĩnh vực kỳ nghỉ trọn gói với các khu nghỉ dưỡng hàng đầu thế giới, vừa công bố dự án Club Med Tremblant nhằm đánh dấu bước tiếp theo của chiến lược mở rộng thị trường Bắc Mỹ. Đây sẽ là khu nghỉ dưỡng thứ hai của thương hiệu tại Canada sau Club Med Québec
More news about: Club Med
Dec 15, 2025, 11:28 ET VIO Med Spa West U Brings Holiday Glow with Special Treatment Offers
CardMeet the Dynamic Duo Behind VIO Med Spa West UDr. Zahra P. Ali is a Texas Medical Board-licensed, ABFM-certified family physician with extensive emergency medicine experience across Houston-area facilities. She serves as Medical Director for VIO Med Spa West U, bringing hands-on expertise
More news about: VIO Med Spa
Dec 15, 2025, 08:00 ET Pele luminosa e firme na estação mais quente: tecnologias estéticas liberadas para o sol
Latina. Formada pelas empresas MedSystems, BeautySystems, Advance Vision, Aeskins, Vydence Medical, Botoclinic, MedSystems Academy, Beauty Academy e Med Banking, a instituição oferece soluções tecnológicas inovadoras para transformar a vida de pacientes, médicos, profissionais de estética e redes, impulsionando
More news about: Medsystems
Dec 15, 2025, 07:00 ET RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells
Robrecht S, Eichhorst B, Hallek M; CLL17 Trial Investigators. Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia. N Engl J Med. 2025 Dec 6. doi: 10.1056/NEJMoa2515458. Epub ahead of print. PMID: 41358601.2 Elías EE, Almejún MB, Colado A, Cordini G,
More news about: RedHill Biopharma Ltd.
Dec 14, 2025, 19:22 ET Patient Enrolment Completed in Phase 2 aGvHD Clinical Trial
2011;2011:601953[2] iPSC = induced pluripotent stem cell.[3] MSC = mesenchymal stem (or stromal) cell.[4] Bloor AJC, et al. Nat Med. 2020;26:1720–1725[5] Kelly K, et al. Nat Med. 2024;30:1556–1558[6] Orphan Drug Designation qualifies Cynata for incentives including extended marketing exclusivity,
More news about: Cynata Therapeutics
Dec 12, 2025, 21:48 ET Loop lanserar en flugfiskeserie på YouTube som belyser bevarande och anknytning
13 december 2025 /PRNewswire/ -- Wild Fish. Wild Places. with Emilie Björkman, en fängslande ny YouTube-serie i dokumentär stil med miljöaktivisten och den berömda flugfiskaren Emilie Björkman, lanserades i höstas. Serien är producerad av Loop, ett företag som är engagerat i att tillverka
More news about: Loop
Dec 12, 2025, 09:18 ET AusperBio Announces AHB-137 Monotherapy Achieved 30% Functional Cure Rate in HBe-negative CHB Patients on Stable Nucleos(t)ide Analogue (NA) Therapy
has developed a proprietary Med-Oligo™ ASO platform which has been shown to substantially enhance the current ASO therapeutics, through novel insights into ASO design. Combining efficient targeted delivery conjugation technologies, the modular Med-Oligo™ Platform empowers ASO therapeutics
More news about: AusperBio Therapeutics Inc.
Dec 12, 2025, 09:00 ET BoomRx Debuts Single Portal for Prescription Sourcing and Fulfillment
system.Built to eliminate the inefficiencies of managing multiple pharmacy portals, state-by-state shipping rules, and fragmented pricing, BoomRx enables med spas, wellness clinics, telemedicine providers, hormone-therapy practices, and other physician offices to access a wide portfolio of medications—including
More news about: BoomRx
Dec 11, 2025, 18:09 ET FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
2024;69(2):166-171.Nowak R, Benatar M, Ciafaloni E, et al. A phase 3 trial of inebilizumab in generalized myasthenia gravis. N Engl J Med. 2025;392(23):2309-2320.Amgen Inc. UPLIZNA (inebilizumab-cdon) US prescribing information. Revised December 2025.Lazaridis K, Tzartos
More news about: Amgen
Dec 11, 2025, 16:40 ET InstaMed® Pharmaceuticals Announces Month-Over-Month Hypergrowth, Successful Study, and Expands Its Patented Peptide Delivery Platform Nationwide
Today, the company announced unprecedented month-over-month growth as demand accelerates across med spas, healthcare clinics, affiliate networks, and wellness channels nationwide. It currently holds nine pending patents.InstaMeds' breakthrough
More news about: InstaMed® Pharmaceuticals
Dec 11, 2025, 14:28 ET Empower Mental Health & Wellness Clinic Joins National Initiative to Support Firefighters' Mental Wellness
BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more.
More news about: Empower Mental Health and Wellness
Dec 11, 2025, 10:00 ET Cision förvärvar Trajaan, utökar AI och sökintelligens över sina plattformar
bild av röst och avsiktKunder kommer nu att kunna kombinera sociala och medieinsikter med sökintelligens för att validera trender, förutsäga efterfrågan och förstå konsumenternas motivationer med större djup.Synlighet i GenAI-driven upptäcktEftersom generativ AI i allt högre
More news about: Cision Ltd.
Dec 11, 2025, 08:30 ET WERFEN APPLAUDS SIGNIFICANT PUBLICATION URGING ACTION ON THE RISKS OF UNDETECTED HEMOLYSIS
opportunities for quality improvement. Clin Chem Lab Med. 2009;47(5):616–618. doi:10.1515/CCLM.2009.132Lippi G, Fontana R, Avanzini P, Sandei F, Ippolito L. Influence of spurious hemolysis on blood gas analysis. Clin Chem Lab Med. 2013;51(8):1651–1654. doi:10.1515/cclm-2012-0802O'Hara
More news about: Werfen
Dec 11, 2025, 08:10 ET ProPharma Expands Operations with New Office in Hyderabad
ProPharmaFor the last 25 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. With deep domain expertise
More news about: ProPharma Group Holdings LLC
Dec 11, 2025, 08:10 ET ProPharma Expands Operations with New Office in Hyderabad
ProPharmaFor the last 25 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. With deep domain expertise
More news about: ProPharma Group Holdings LLC
Dec 10, 2025, 18:30 ET Astellas to Present New Clinical Data Across Its Gastrointestinal Cancers Portfolio at 2026 ASCO GI Cancers Symposium
MA, et al. Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial. Nat Med. 2023;29(8):2133-2141.3 Lee, JK et al. Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes
More news about: Astellas Pharma Inc.
Dec 10, 2025, 17:45 ET ECOG-ACRIN and Caris Life Sciences unveil first findings from a multi-year collaboration to advance AI-powered multimodal tools for breast cancer recurrence risk stratification
are postmenopausal or older than 50 at diagnosis, and also in most patients who are younger than 50 or premenopausal (Sparano JA et al. N Engl J Med. 2018). With longer follow-up (12 years of survival and recurrence outcomes), the main study findings remain unchanged.One critically important
More news about: Caris Life Sciences
Dec 10, 2025, 11:12 ET Lucinity lanserer Human AI-drevne FinCrime-operasjoner og utnevner ny administrerende direktør for neste kapittel
regulatoriske forventninger. Mens mange ønsker fordelene med AI, sliter de fleste med å ta det i bruk på grunn av eldre systemer, styringsmessige begrensninger og operasjonell risiko.Lucinitys nye tjeneste løser dette problemet ved å ta på seg arbeidsmengden med FinCrime-etterforskning under SLA, mens institusjonene
More news about: Lucinity
Dec 10, 2025, 11:03 ET Lucinity lanserar Human AI-drivna FinCrime-operationer och utser ny VD för nästa kapitel
Chairman.Förstärkt styrelse och nordisk momentumLucinity har utökat sin styrelse med Kristian Nygaard Johansen och Bragi Fjalldal, tillsammans med stöd från Eric från byFounders. Styrelsen för med sig djup erfarenhet av att skala nordiska finansiella och teknikföretag."Det finns tydlig
More news about: Lucinity
Dec 10, 2025, 10:58 ET Lucinity lancerer Human AI-drevne FinCrime-operationer og udnævner ny administrerende direktør til næste kapitel
styring."GK vil fortsætte med at vejlede Lucinitys langsigtede vision, innovation og strategiske partnerskaber som Executive Chairman.Styrket bestyrelse og nordisk momentumLucinity har udvidet sin bestyrelse med Kristian Nygaard Johansen og Bragi Fjalldal, sammen med støtte fra Eric fra
More news about: Lucinity
Dec 10, 2025, 08:01 ET ProRx Pharma Expands State-of-the-Art Facilities to Fuel Growing Demand for Personalized and Preventative Medicine
safe, compliant, and high-quality compounded sterile and nonsterile preparations to physician practices, medical clinics, and med spas across the country. With a focus on preventative health, regulatory excellence, reliability, and customer service, ProRx partners
More news about: ProRx Pharma
Dec 09, 2025, 19:26 ET Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody
References[1]. J Transl Int Med. 2022;10(2):134-145[2]. Sci
More news about: Innovent Biologics
Dec 09, 2025, 14:06 ET NCCN Summit Seeks to Improve Care for Veterans and First Responders with Cancer from Line-of-Duty Exposure
hope and life-saving cancer care. No one who served should have to fight for cancer treatment or access to clinical trials," agreed Mel Mann, MBA, MEd, U.S. Army Major (retired), Survivor, Advocate.Speakers noted that veterans and firefighters can face elevated risk due to exposures while
More news about: National Comprehensive Cancer Network
Dec 09, 2025, 10:00 ET Cision utnämner Amy Jones till Chief Marketing Officer
Vistaprint. "Jag är exalterad över att gå med i Cision vid ett sådant avgörande ögonblick", säger Amy Jones, CMO för Cision. Cisions skala, data och AI-drivna innovation utgör en enorm möjlighet. Jag ser fram emot att samarbeta med ELT och våra globala team för att påskynda tillväxten
More news about: Cision Ltd.